Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

Women prescribed a GLP-1 receptor agonist up to 2 years before conception were less likely to develop hypertensive disorders ...

Flowers has documented for several quarters a consumer shift away from traditional loaves toward more “differentiated and premium items” .

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

WVU medicine is conducting a trial to combat weight gain after patients stop taking GLP-1 drugs such as Ozempic. Officials ...

A majority with overweight/obesity discontinue within a year, but the rate is higher among those without type 2 diabetes.

The spot “is a clear violation” of the FDCA, “which requires that advertising for prescription drugs — including compounded ...

Nephrologists jumped on the GLP-1 bandwagon well before Novo Nordisk won FDA approval for Ozempic in chronic kidney disease ...

They're known to aid in blood sugar control and, now, weight loss — however, according to a sweeping new study, the popular ...

Their relationship is still going strong. Patrick Mahomes and Travis Kelce said that it was 'a great honor' for the president ...

A small percentage of patients taking GLP-1 medications have experienced vision problems, but a direct causal link with the ...

WVU Medicine is playing a lead role in a national clinical study of a minimally invasive surgical procedure for people who've ...